Skip to main content

Table 1 Trial methodological quality

From: Surfactant therapy for acute respiratory failure in children: a systematic review and meta-analysis

Trial

Allocation concealment reported? (Method used)

Who was reported to be blinded? (Who administered the intervention?)

Completeness of follow-up reported?a

Groups similar at baseline?b

Ventilation algorithm described?

Criteria for rescue therapyc

Luchetti, 1998

Yes (sealed envelopes)

Not reported

Not reported

Yes

Yes

Not reported

Willson, 1999

Yes (opaque sealed envelopes)

Unblinded

91%

Lower PRISM scores in control group (9 versus 12)

Yes

No

Tibby, 2000

Not reported

Care providers (investigators not involved in patient care)

Not reported

Yes

Yes

Not reported

Luchetti, 2002

Yes (sealed envelope)

Outcome assessors (investigators)

Not reported

Yes

Yes

No

Moller, 2003

Yes (central telephone)

Unblinded

87%

Yes

Yes

Yes

Willson, 2005

Yes (opaque sealed envelopes)

Care providers, investigators (respiratory therapist not involved in patient care)

100%

More immunosuppressed in control group (30 versus 22)

Yes

No

  1. aPatients randomized but not included in the analysis. bPotentially clinically significant differences in age, aetiology, severity of illness (Pediatric Risk of Mortality (PRISM) score) and immunosuppression. cA priori criteria for the use of extracorporeal membrane oxygenation, high-frequency oscillatory ventilation, nitric oxide and open-label surfactant.